Results 41 to 50 of about 29,949 (204)

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Effects of a single subcutaneous dose of enoxaparin on veterinary viscoelastic coagulation monitor variables in healthy cats: Double blind, placebo controlled cross‐over trial

Journal of Veterinary Internal Medicine, 2023
Background Cats placed on anticoagulant medication require frequent monitoring. The veterinary viscoelastic coagulation monitor (VCM‐Vet) could provide a convenient and cost‐effective monitoring, enabling therapeutic decision making.
Ivayla D. Yozova, Michael S. Kent, Karl E. Jandrey   +2 more
doaj   +1 more source

Effect of enoxaparin on histological changes of colon.

, 2015
Representative hematoxylin and eosin stained colon sections of healthy and colitis mice with and without enoxaparin. Scale bars = 100 μm for 400 × and 400 μm for 100 × magnification.
Sarron Randall-Demllo (776243), Rahul P. Patel (698431), Niall Stewart (698428), Sukhwinder Singh Sohal (317561), Nuri Gueven (134653), Rajaraman D. Eri (755888), Qi Ying Lean (755887), Gregory M. Peterson (564167)   +7 more
core   +1 more source

Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial

BMC Musculoskeletal Disorders, 2022
Background Pharmacological and mechanical thromboprophylaxis are frequently used together after total knee arthroplasty (TKA). Most studies in this context compare anticoagulants versus a combination of these drugs with an intermittent pneumatic ...
João Alberto Ramos Maradei-Pereira, Marcel Lobato Sauma, Marco Kawamura Demange   +2 more
doaj   +1 more source

Raising the bar: Utilizing quality improvement tools to increase compliance with clinical care guidelines in inflammatory bowel disease patients

JPGN Reports, EarlyView.
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri, Emi Suzuki, Laura Bauman, Brent Polk, Jeannie S. Huang   +4 more
wiley   +1 more source

Comparative Studies on Branded Enoxaparin and a US Generic Version of Enoxaparin

Clinical and Applied Thrombosis/Hemostasis, 2012
Enoxaparin, a complex, biologically derived low-molecular-weight heparin, is approved for a range of clinical indications. This study was carried out to compare the potency profile and pharmacodynamic responses of branded enoxaparin (Lovenox; Sanofi, US) with a generic enoxaparin (enoxaparin sodium injection, USP).
Jeanine M, Walenga, Walter P, Jeske, Debra, Hoppensteadt, Josephine, Cunanan, Hussein, Khan, Vicki, Escalante, Jawed, Fareed, Mamdouh, Bakhos   +7 more
openaire   +2 more sources

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome

, 2007
Caroline Schmidt-Lucke, Heinz-Peter SchultheissCharité Medical University Berlin, Campus Benjamin Franklin, Dept. of Cardiology and Pulmology, GermanyAbstract: Non-ST elevation acute coronary syndrome (NSTE-ACS) refers to a cardiovascular disorder
Caroline Schmidt-Lucke, Heinz-Peter Schultheiss   +1 more
core   +1 more source

Does the use of postoperative low-molecular-weight heparin in patients with lung cancer increase tube drainage?

Asian Journal of Surgery, 2020
Summary: Background: The objectives of this study are to assess the chest drainage volumes of patients undergoing anatomic resection of non-small cell lung carcinoma and to determine the safety and effectiveness of administering enoxaparin for ...
Hıdır Esme, Atilla Can, Abidin Şehitogullari   +2 more
doaj   +1 more source

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism

INNOVATIONS in Pharmacy, 2023
Background: Evidence suggests that goal anti-Xa levels are achieved in only 33% of critically ill patients receiving standard prophylactic enoxaparin dosing.
Aliya Abdulla, Caitlin M. Williams, Trisha N. Branan, Susan E. Smith   +3 more
doaj   +1 more source